arginine and plx4032

arginine has been researched along with plx4032 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Allegra, M; Bahadoran, P; Ballotti, R; Giacchero, D; Hofman, P; Lacour, JP; Le Duff, F; Long-Mira, E; Passeron, T	1
Bedogni, B; Boland, GM; Chang, M; Flaherty, K; Frederick, DT; Freitas, JT; Gao, M; Herlyn, M; Li, Y; Lu, Y; Marusak, C; Miao, B; Mills, GB; Moll, T; Sullivan, RJ; Tan, J; Thakur, V; Thakur, VS; Xiao, M; Zhang, G; Zmina, PM	1

Other Studies

2 other study(ies) available for arginine and plx4032

Article	Year
Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19 Topics: Aged; Antineoplastic Agents; Arginine; Back; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Imidazoles; Indoles; Leucine; Lung Neoplasms; MAP Kinase Signaling System; Melanoma; Niacinamide; Oximes; Phenylurea Compounds; Point Mutation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sorafenib; Sulfonamides; Vemurafenib	2013
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 11-15, Volume: 26, Issue:22 Topics: Animals; Arginine; Cell Line, Tumor; Drug Resistance, Neoplasm; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Integrin beta1; Matrix Metalloproteinase 14; Melanoma; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Signal Transduction; Sulfones; Transforming Growth Factor beta; Vemurafenib	2020

Article

Year

Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19

Topics: Aged; Antineoplastic Agents; Arginine; Back; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Imidazoles; Indoles; Leucine; Lung Neoplasms; MAP Kinase Signaling System; Melanoma; Niacinamide; Oximes; Phenylurea Compounds; Point Mutation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sorafenib; Sulfonamides; Vemurafenib

2013

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 11-15, Volume: 26, Issue:22

Topics: Animals; Arginine; Cell Line, Tumor; Drug Resistance, Neoplasm; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Integrin beta1; Matrix Metalloproteinase 14; Melanoma; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Signal Transduction; Sulfones; Transforming Growth Factor beta; Vemurafenib

2020